Linearity [Regulatives / Guidelines]

posted by Ohlbe – France, 2022-01-24 13:16 (378 d 16:37 ago) – Posting: # 22751
Views: 1,433

Hi John,

Does your drug show linear PK ? If not: does it show more-than-proportional increase (then the highest strength would be more sensitive to show differences in BA) or less-than-proportional increase (lowest strength would be more sensitive, giving you good arguments) ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
30 visitors (0 registered, 30 guests [including 19 identified bots]).
Forum time: 05:53 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5